Abstract
A double-blind trial of the tanned-erythrocyte electrophoretic mobility test for cancer has been carried out. This included 70 normal subjects as controls, 61 subjects with disease other than cancer, and 229 cancer patients. Slowing values generally increased in the order given, with certain diseases having values within the range positive for cancer. Exposure to viral infection also tended to produce false positives. Slowing values above 50%, however, appear to be definitely associated with cancer. For the middle range of slowing values (25-50%) there is some overlap between the 3 groups, so that a statistical probability of the presence of malignancy is available from the test. With slowing values below 25% there is little likelhood of cancer. Tumour type influences the test result, as does, to a lesser extent, tumour bulk.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arvilommi H., Dale M. M., Desai H. N., Mongar J. L., Richardson M. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer. Br J Cancer. 1977 Nov;36(5):545–549. doi: 10.1038/bjc.1977.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crozier E. H., Hollinger M. E., Woodend B. E., Robertson J. H. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis. J Clin Pathol. 1976 Jul;29(7):608–609. doi: 10.1136/jcp.29.7.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dyson J. E., Corbett P. J. Effect of lymphocyte supernatants on the electrophoretic mobility of erythrocytes: significance in cancer diagnosis. Br J Cancer. 1978 Sep;38(3):401–410. doi: 10.1038/bjc.1978.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
- Petty H. R., Ware B. R., Remold H. G., Rocklin R. E. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages. J Immunol. 1980 Jan;124(1):381–387. [PubMed] [Google Scholar]
- Preece A. W., Light P. A. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors. Clin Exp Immunol. 1974 Dec;18(4):543–552. [PMC free article] [PubMed] [Google Scholar]
- Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer. 1973 Jan;27(1):1–9. doi: 10.1038/bjc.1973.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation. Lancet. 1972 Sep 23;2(7778):627–629. doi: 10.1016/s0140-6736(72)93018-8. [DOI] [PubMed] [Google Scholar]
- Rawlins G. A., Wood J. M., Bagshawe K. D. Macrophage electrophoretic mobility (MEM) with myelin basic protein. Br J Cancer. 1976 Dec;34(6):613–618. doi: 10.1038/bjc.1976.221. [DOI] [PMC free article] [PubMed] [Google Scholar]